RK-4 injection for large stroke on one side of the brain
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests an injection given into the skull bone within 24 hours of a major stroke. It is for people who have a large stroke on one side of the brain and have not improved after standard clot-removal treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You had a large stroke on one side of the brain in the middle cerebral artery area
- You can get the injection within 24 hours of when symptoms started
- Your stroke is severe (NIHSS score 16-32) and you have weakness in arm and leg
- If you had clot-removal treatment, it did not open the blocked artery enough
- You do not have bleeding in the brain or other major health problems listed in the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, RK-4, given via injection into the skull for people who have had a major stroke. It's for those who have not improved enough after standard treatment like clot removal.
This trial tests a new drug (RK-4) delivered directly through the skull bone to treat patients with large strokes in the brain's main blood vessel. The goal is to see if this approach is safe and can help restore brain function when standard stroke treatments aren't working well enough.
This trial tests a clot-busting drug for people who had a stroke more than 4.5 hours ago. It uses a special CT scan to see if the treatment can still help them.
This trial tests an investigational drug, QHRD106, given as an injection for people who have had a moderate-to-severe acute ischemic stroke. It aims to see if the drug can help recovery when given within 24 hours after the stroke starts, and it is for patients who are not receiving standard clot-busting treatment.
This trial tests whether a simple remote “arm conditioning” treatment started soon after an acute ischemic stroke can improve outcomes and safety. It may help some patients recover better by supporting the body’s protective response to stroke.
This trial tests an investigational injection called KPCXM18 for people having an acute ischemic stroke. It is given within 12 hours of symptom onset, in addition to standard clot-dissolving treatment, to see if it improves recovery and safety.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.